Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design
- 28 February 2023
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 18 (8) , e202200615
Abstract
Herein, we describe a systematic SAR‐ and SPR‐investigation of the peptidomimetic hydroxy‐proline based VHL‐ligand VH032, from which most to‐date published VHL‐targeting PROTACs have been derived. This study provides for the first time a consistent data set which allows for direct comparison of structural variations including those which were so far hidden in patent literature. The gained knowledge about improved VHL binders was used to design a small library of highly potent BRD4‐degraders comprising different VHL exit vectors. Newly designed degraders showed favorable molecular properties and significantly improved degradation potency compared to MZ1.Keywords
This publication has 36 references indexed in Scilit:
- Thioamide substitution to probe the hydroxyproline recognition of VHL ligandsBioorganic & Medicinal Chemistry, 2018
- 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein DegradationJournal of the American Chemical Society, 2018
- Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)Journal of Medicinal Chemistry, 2017
- Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH InhibitionChemistry – A European Journal, 2017
- Structural basis of PROTAC cooperative recognition for selective protein degradationNature Chemical Biology, 2017
- Structure-Guided Design and Optimization of Small Molecules Targeting the Protein–Protein Interaction between the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar AffinitiesJournal of Medicinal Chemistry, 2014
- Small‐Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1αAngewandte Chemie International Edition, 2012
- Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein InterfaceChemistry & Biology, 2012
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α InteractionJournal of the American Chemical Society, 2012
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007